Quo Vadis Temporomandibular Disorders? By 2050, the Global Prevalence of TMD May Approach 44
- PMID:40648789
- PMCID: PMC12249499
- DOI: 10.3390/jcm14134414
Quo Vadis Temporomandibular Disorders? By 2050, the Global Prevalence of TMD May Approach 44
Abstract
Background/objectives: Currently, temporomandibular disorders (TMDs) represent a significant public health concern, affecting approximately 34% of the global population. The primary aim of this study was to determine the prevalence of TMDs in the year 2050. A secondary objective was to estimate the prevalence for the years 2030, 2075, and 2100.
Methods: The methodology of a prognostic study was replicated and adapted to develop prevalence projections for TMDs, utilising the most recent meta-analysis of the global prevalence of temporomandibular disorders and analyses conducted within the R environment.
Results: Projections indicate a gradual increase in the global prevalence of TMDs over the coming decades. In 2030, the estimated prevalence is 39% (95% confidence interval: 34-44%). This figure is expected to rise to 41% [36-46%] by 2040 and reach 44% [39-49%] by 2050. The upward trend continues, with projections suggesting a prevalence of 47% [42-52%] in 2075 and 49% [44-54%] by 2100. These data highlight a steadily increasing global burden of TMDs.
Conclusions: By the year 2050, the global prevalence of TMDs is projected to reach 44%, which, according to estimates, corresponds to approximately 4,252,160,000 individuals. By 2030, 39% of the population is projected to experience TMDs. By 2075, the global TMD prevalence is expected to rise to 47%, and, by 2100, it could increase further to 49% of the global population. Urbanisation affects TMD prevalence in a region-dependent manner; a significant decrease was observed in Asia, while, in the Americas and Europe, the association was negligible. Globally, the lack of a clear impact of urbanisation on TMD occurrence suggests the influence of environmental and cultural factors.
Keywords: 2050; 2075; 2100; TMDs; epidemiology; meta-analysis; prediction; prevalence; temporomandibular disorders; trends.
Conflict of interest statement
The author declares no conflicts of interest.
Figures
References
- Szabolcsi R. Quo Vadis, Domine? Technol. Soc. Sci. J. 2020;9:50–57. doi: 10.47577/tssj.v9i1.964. - DOI
- Daubner-Bendes R., Kovács S., Niewada M., Huic M., Drummond M., Ciani O., Blankart C.R., Mandrik O., Torbica A., Yfantopoulos J., et al. Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges. Front. Public Health. 2020;8:612410. doi: 10.3389/fpubh.2020.612410. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources


